Johnson & Johnson reported $25.3 billion in revenue in the second quarter, surpassing the average estimate from analysts, but disappointing demand for its medic

Johnson & Johnson reported $25.3 billion in revenue in the second quarter, surpassing the average estimate from analysts, but disappointing demand for its medical devices overshadowed better-than-expected drug sales. Madison Muller reports [▻](https://video.twimg.com/am…